Heart Health and Longevity

At 56, Roger—a tech executive—knows the value of precision, innovation, and proactive problem-solving. But when a routine cardiac calcium screening revealed significant plaque buildup in his vessels, the stakes became personal. The diagnosis carried serious implications: increased risk of heart attack, stroke, and heart failure. For Roger, a husband and father of two daughters in their twenties, the message was clear—he needed to act, and fast.

Roger’s journey began with determination and a series of difficult trials. He tried every statin available, hoping to lower his cholesterol and reduce his cardiac risk. But the side effects were relentless: headaches, body aches, and debilitating muscle cramps. “I was miserable,” he recalls. “I couldn’t do my job. I couldn’t live the life I wanted.”

Next came Repatha, a self-injected medication that offered some relief—but not enough. The frequent dosing and lingering side effects still interfered with his quality of life. That’s when his cardiologist introduced him to Leqvio, a twice-yearly injection with a low side effect profile. It was a game-changer.

“Leqvio changed everything,” Roger says. “No side effects. My cholesterol is under control. I feel great. I truly believe this medication will give me a longer, healthier life.”

Roger’s care team at Sage Infusion played a pivotal role in this transformation. He was the very first patient seen at the newly opened Sage Infusion clinic in St. Pete—a milestone he wears with pride. “Everyone treats you like family,” he says. “I have the best of everything because of Sage Infusion.”

From the convenience of a nearby clinic to the warmth of a team that greets him with a smile and checks in on his well-being, Roger feels supported every step of the way. Sage Infusion even went to bat for him with his insurance company, crafting a detailed Letter of Medical Necessity to ensure coverage for his life-changing therapy.

Today, Roger continues to thrive—professionally, personally, and physically. His story is a testament to the power of personalized care, persistence, and the right therapeutic match. Sage Infusion helped improve his health and with it, his future.

Leqvio (inclisiran) is a cutting-edge cholesterol-lowering therapy designed for long-term cardiovascular risk reduction. Administered just twice a year after the initial doses, Leqvio works by targeting a specific protein (PCSK9) that affects LDL cholesterol levels. Its low side effect profile and convenient dosing schedule make it an ideal option for patients who struggle with statin intolerance or adherence. For patients like Roger, Leqvio offers not just improved lab results—but renewed quality of life.